MYNZ Stock Earnings: Mainz Biomed Beats EPS, Misses Revenue for Q4 2023

    Date:

    Mainz Biomed (NASDAQ:MYNZ) just reported results for the fourth quarter of 2023.

    • Mainz Biomed reported earnings per share of -24 cents. This was above the analyst estimate for EPS of -32 cents.
    • The company reported revenue of $214,761.
    • This was 20.46% worse than the analyst estimate for revenue of $270,000.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Go Source

    Chart

    Sign up for Breaking Alerts

    Share post:

    Popular

    More like this
    Related

    It’s Still an Uptrend, But…

    The trend is your friend.  This adage tends to...

    Stocks Comeback on Lighter Geopolitical Pressures: Apr. 18, 2024

    Investors’ optimism that the worst of the Middle East...

    Market Movers: From Fed Rates To Sector Shakes

    Your Privacy When you visit any website it may use...

    The long / short report April 2024

    Your Privacy When you visit any website it may use...